melanotan hair risks: Why dermatologists say no TanAdera Golden Balm (Melanotan-2) -

These mechanisms explain the interest in CJC-1295 among researchers studying injury recovery protocols

These outcomes occurred with drug exposure during periods of renal development in rats that correspond to the late second and third trimester of human renal development

At #AADInnovation2026, we presented new data from two pivotal Phase 3 studies of our investigational oral treatment for people with moderate-to-severe plaque #psoriasis, including results across high-impact sites

This guidance follows the FDAs approval of Wegovy (semaglutide) for an expanded indication to reduce the risk of major cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with established cardiovascular disease (CVD) and who are either obese or overweight